Pentheroudakis 416 G Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ,
Combination chemotherapy in advanced adrenocortical carcinoma, N. Engl. J, p.425 ,
Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel, Journal of Clinical Oncology, vol.28, issue.23, pp.401-402, 2010. ,
DOI : 10.1200/JCO.2009.27.5958
Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.2, pp.455-461, 2014. ,
DOI : 10.1210/jc.2013-2856
Adjuvant mitotane treatment for adrenocortical 436 carcinoma, N. Engl. J. Med, vol.356, issue.23, pp.2372-2380, 2007. ,
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients, British Journal of Cancer, vol.69, issue.5, pp.947-951, 1994. ,
DOI : 10.1038/bjc.1994.183
Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma, Cancer, vol.62, issue.6, pp.1385-1392, 2001. ,
DOI : 10.1002/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2
The long-term survival in adrenocortical carcinoma with 450 active surgical management and use of monitored mitotane, Endocr. Relat. Cancer, vol.45117, issue.1, pp.265-272, 2010. ,
Plasma Concentrations of o,p???DDD, o,p???DDA, and o,p???DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.6, pp.1844-1851, 2011. ,
DOI : 10.1210/jc.2010-2676
The treatment of adrenocortical 458 carcinoma with o,p'-DDD: prognostic implications of serum level monitoring, Eur J Cancer, vol.459 ,
The distribution ofo,p???-DDD (Mitotane) among serum lipoproteins in normo- and hypertriglyceridemia, Cancer Chemotherapy and Pharmacology, vol.51, issue.Suppl, pp.331-334, 1992. ,
DOI : 10.1007/BF00685956
Possible 464 mechanism and treatment of o,p'DDD-induced hypercholesterolaemia, Q. J. Med. 465, vol.84, issue.305, pp.671-679, 1992. ,
Mitotane (o,p???-DDD) Administration Raises the Serum Level of High Density Lipoprotein (HDL) in Normotriglyceridemia, Hormone and Metabolic Research, vol.25, issue.04, pp.240-241, 1993. ,
DOI : 10.1055/s-2007-1002086
Prospective evaluation 476 of mitotane toxicity in adrenocortical cancer patients treated adjuvantly, Endocr. Relat. Cancer, vol.47715, issue.4, pp.1043-1053, 2008. ,
Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study, International Journal of Endocrinology, vol.143, issue.11, pp.624962-481, 2013. ,
DOI : 10.1186/1476-511X-10-181
Stimulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme a reductase activity by o,p???-DDD, Biochemical Pharmacology, vol.31, issue.5, pp.857-860, 1982. ,
DOI : 10.1016/0006-2952(82)90474-9
Studies of the pharmacology of o,p'DDD in man, J. Lab. Clin. Med, vol.58, pp.296-484, 1961. ,
The lack of antitumor effects of o,p'DDA 487 excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment, Horm Cancer, vol.4885, issue.5, pp.312-323, 2014. ,
Ultrastructure of adrenal cortex of the dog during treatment 490 with DDD, J. Natl. Cancer Inst, vol.29, pp.127-159, 1962. ,
Morpho-functional effects of mitotane on mitochondria in human adrenocortical 493 cancer cells, Endocr. Relat. Cancer, 2013. ,
Mitotane alters mitochondrial respiratory chain 496 activity by inducing cytochrome c oxidase defect in human adrenocortical cells, Endocr. Relat. 497 Cancer, vol.20, issue.3, pp.371-381, 2013. ,
New response evaluation criteria in solid tumours: revised RECIST guideline 501 (version 1.1), Eur. J. Cancer, vol.45, issue.2, pp.228-247, 2009. ,
Assay of 503 mitochondrial respiratory chain complex I in human lymphocytes and cultured skin fibroblasts, p.504 ,
Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.16, issue.6, pp.763-772, 1996. ,
DOI : 10.1161/01.ATV.16.6.763
The role of high density lipoproteins in the biodistribution of two radioiodinated probes in the rat, Toxicology and Applied Pharmacology, vol.77, issue.1, pp.47-57, 1985. ,
DOI : 10.1016/0041-008X(85)90266-2